Sofía Rivera

2.2k total citations
89 papers, 842 citations indexed

About

Sofía Rivera is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sofía Rivera has authored 89 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 32 papers in Cancer Research and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sofía Rivera's work include Breast Cancer Treatment Studies (30 papers), Advanced Radiotherapy Techniques (20 papers) and Breast Lesions and Carcinomas (12 papers). Sofía Rivera is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Advanced Radiotherapy Techniques (20 papers) and Breast Lesions and Carcinomas (12 papers). Sofía Rivera collaborates with scholars based in France, Netherlands and Spain. Sofía Rivera's co-authors include Éric Deutsch, C. Bourgier, Christophe Hennequin, Marie‐Catherine Vozenin, L. Quéro, Jean Bourhis, Jean-Jacques Monsuez, Caroline Rivera, Yohann Loriot and Valérie Haydont and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sofía Rivera

78 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofía Rivera France 16 277 261 247 214 174 89 842
Zhaozhi Yang China 18 326 1.2× 397 1.5× 273 1.1× 151 0.7× 191 1.1× 57 986
Jinli Ma China 17 211 0.8× 235 0.9× 400 1.6× 328 1.5× 351 2.0× 55 913
Imogen Locke United Kingdom 16 208 0.8× 288 1.1× 301 1.2× 246 1.1× 298 1.7× 39 798
Zsolt Gabos Canada 16 462 1.7× 211 0.8× 499 2.0× 339 1.6× 264 1.5× 40 1.2k
Pelagia Tsoutsou Switzerland 15 227 0.8× 154 0.6× 338 1.4× 284 1.3× 105 0.6× 44 839
Nadia Pasinetti Italy 13 270 1.0× 160 0.6× 368 1.5× 160 0.7× 76 0.4× 38 809
Hani Ashamalla United States 17 276 1.0× 125 0.5× 371 1.5× 322 1.5× 208 1.2× 70 1.0k
Dae Sik Yang South Korea 16 204 0.7× 110 0.4× 190 0.8× 138 0.6× 155 0.9× 85 806
M.I. Saunders United Kingdom 21 276 1.0× 213 0.8× 452 1.8× 377 1.8× 246 1.4× 57 1.2k
Antonio Gómez‐Caamaño Spain 17 297 1.1× 130 0.5× 430 1.7× 473 2.2× 84 0.5× 58 963

Countries citing papers authored by Sofía Rivera

Since Specialization
Citations

This map shows the geographic impact of Sofía Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Rivera more than expected).

Fields of papers citing papers by Sofía Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofía Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Rivera. The network helps show where Sofía Rivera may publish in the future.

Co-authorship network of co-authors of Sofía Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Sofía Rivera. A scholar is included among the top collaborators of Sofía Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofía Rivera. Sofía Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beddok, Arnaud, Guillaume Breton, Arwa Ali, et al.. (2025). Enhancing Expertise in Reirradiation: Results from a Training Workshop Organized by Unicancer, the Federation of French Cancer Centers. Journal of Cancer Education. 40(6). 987–992.
2.
Bajardi, Paolo, Guido Bologna, Francesco Bonchi, et al.. (2024). PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification. Journal of Cancer Policy. 43. 100537–100537.
3.
Giudici, Fabiola, Chiara Bellini, S. Bockel, et al.. (2024). Feasibility and Safety of the “One-Week Breast Radiation Therapy” Program. Clinical Oncology. 36(9). e333–e341.
4.
Piffoux, Max, G. Delpon, Alain Alexis, et al.. (2023). Insights on the carbon footprint of radiotherapy in France. Cancer/Radiothérapie. 27(6-7). 487–490. 3 indexed citations
5.
Josipović, Mirjana, Jorge S. López, P. Remeijer, et al.. (2023). What does “Advanced” mean in 2023? reflecting on 10 years of the ESTRO advanced Skills in modern radiotherapy course. Technical Innovations & Patient Support in Radiation Oncology. 29. 100227–100227.
6.
Guihard, S., P. Giraud, X. Liem, et al.. (2023). Données de vie réelle en radiothérapie : le data farming du groupe Unitrad. Cancer/Radiothérapie. 27(6-7). 455–459.
7.
Espenel, Sophie, Cyrus Chargari, Pierre Blanchard, et al.. (2022). Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials. European Journal of Cancer. 171. 242–258. 6 indexed citations
8.
Antoni, D., L. Claude, Anne Laprie, et al.. (2022). Les essais qui changent les pratiques : le point en 2022. Cancer/Radiothérapie. 26(6-7). 823–833. 1 indexed citations
9.
Bockel, S., et al.. (2021). Hypofractionnement extrême en pratique : les nouvelles indications dans les cancers du sein. Cancer/Radiothérapie. 25(6-7). 679–683. 2 indexed citations
10.
Thureau, S., et al.. (2020). Irradiation en situation postopératoire après reconstruction mammaire. Cancer/Radiothérapie. 24(6-7). 645–648.
11.
Sun, Runbin, Samy Ammari, S. Bockel, et al.. (2020). 1675MO Screening of COVID-19 disease based on chest CT and PCR for cancer patients undergoing radiotherapy in a French coronavirus hotspot. Annals of Oncology. 31. S994–S994. 3 indexed citations
12.
Lerebours, Florence, Marina Pulido, Emmanuelle Fourme, et al.. (2020). Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials. British Journal of Cancer. 122(6). 759–765. 13 indexed citations
13.
Xu, Liang, Adrien Briaux, Véronique Becette, et al.. (2018). Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). Journal of Hematology & Oncology. 11(1). 124–124. 23 indexed citations
14.
Arriagada, R., Marcos Santos, C. Bourgier, et al.. (2017). Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. European Journal of Cancer. 76. 45–51. 31 indexed citations
15.
Deutsch, Éric, C. Le Péchoux, Laurence Faivre, et al.. (2015). Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer. Annals of Oncology. 26(6). 1223–1229. 42 indexed citations
16.
Sole, Claudio V., Felipe A. Calvo, Javier Serrano, et al.. (2014). Post-chemoradiation intraoperative electron-beam radiation therapy boost in resected locally advanced rectal cancer: Long-term results focused on topographic pattern of locoregional relapse. Radiotherapy and Oncology. 112(1). 52–58. 12 indexed citations
17.
Rivera, Sofía, et al.. (2013). Curiethérapie du cancer du sein. Cancer/Radiothérapie. 17(2). 125–129. 6 indexed citations
18.
Hennequin, Christophe, L. Quéro, & Sofía Rivera. (2011). Radiosensibilité des cancers du foie. Cancer/Radiothérapie. 15(1). 39–42. 14 indexed citations
19.
Dewas, S., Y. Pointreau, Sofía Rivera, et al.. (2009). Démographie des internes en oncologie–radiothérapie en France en 2008 : état et perspectives pour les trois prochaines années. Cancer/Radiothérapie. 13(3). 153–160. 8 indexed citations
20.
Haydont, Valérie, O. Gilliot, Sofía Rivera, et al.. (2007). Successful Mitigation of Delayed Intestinal Radiation Injury Using Pravastatin is not Associated with Acute Injury Improvement or Tumor Protection. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1471–1482. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaozhi Yang Breakdown of academic impact, for papers by Jinli Ma Breakdown of academic impact, for papers by Imogen Locke Breakdown of academic impact, for papers by Zsolt Gabos Breakdown of academic impact, for papers by Pelagia Tsoutsou Breakdown of academic impact, for papers by Nadia Pasinetti Breakdown of academic impact, for papers by Hani Ashamalla Breakdown of academic impact, for papers by Dae Sik Yang Breakdown of academic impact, for papers by M.I. Saunders Breakdown of academic impact, for papers by Antonio Gómez‐Caamaño
Rankless by CCL
2026